Can this new hearing aid beat AirPods? trial launches
NCT ID NCT07572357
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new hearing aid device (RH210A) in 24 adults with self-perceived mild-to-moderate hearing loss. Participants will compare the investigational device to Apple AirPods Pro with a hearing aid feature. The goal is to see if the new device improves hearing and speech understanding in noise, and to check its safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RH210A hearing aid device
- What this could lead to
- If successful, this could provide a new, effective over-the-counter option for people with mild-to-moderate hearing loss.
- What could go wrong
- This is a small early-stage trial with only 24 participants, so results may not apply to everyone. The device is compared to an existing FDA-cleared product, so major breakthroughs are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING IMPAIRMENT, SENSORINEURAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Acoustic Laboratories
RECRUITINGMacquarie Park, New South Wales, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.